Technical Analysis for MXCT - Maxcyte Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 312.00 | -0.32% | -1.00 |
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -0.32% | |
| Narrow Range Bar | Range Contraction | -0.32% | |
| Lower Bollinger Band Walk | Weakness | -0.32% | |
| Inside Day | Range Contraction | -0.32% | |
| Oversold Stochastic | Weakness | -0.32% | |
| Doji - Bullish? | Reversal | -0.95% | |
| Lower Bollinger Band Walk | Weakness | -0.95% | |
| Outside Day | Range Expansion | -0.95% | |
| Lower Bollinger Band Touch | Weakness | -0.95% | |
| Oversold Stochastic | Weakness | -0.95% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 8 hours ago |
| Possible NR7 | 1 day ago |
| Down 1% | 1 day ago |
| Lower Bollinger Band Support | 2 days ago |
| Lizard Bullish Entry | 2 days ago |
Get a Trading Assistant
Maxcyte Inc Description
MaxCyte, Inc. focuses on cell-based medicines. The Company's cell modification technology, Flow electroporation, is used for discovery, development and manufacture of small molecule, biologic and cell-based therapeutics. The Company's products include instruments, processing assemblies and insourcing services. Its instruments include systems, such as the MaxCyte STX, the MaxCyte VLX and the MaxCyte GT. The Company's MaxCyte GT Flow Transfection System, the MaxCyte STX Scalable Transfection System and the MaxCyte VLX Large Scale Transfection System enable the development and production of transfected cells for an array of applications. The Company offers a platform, which enables the engineering of a range of cells, including human primary cells. Its products are used in applications, including drug discovery, protein production and cell therapy. The Company offers messenger ribonucleic acid (mRNA) CAR T-cell based platform for immuno-oncology indications, including solid cancers.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Engineering Biotechnology Medicine Life Sciences Cancer Branches Of Biology Sourcing Biology Oncology Mr Drug Discovery Therapy Cell Therapy Cancers Molecular Biology Gene Delivery Applied Genetics Laboratory Techniques Solid Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 430.0 |
| 52 Week Low | 170.0 |
| Average Volume | 26,240 |
| 200-Day Moving Average | 331.27 |
| 50-Day Moving Average | 345.62 |
| 20-Day Moving Average | 333.13 |
| 10-Day Moving Average | 324.20 |
| Average True Range | 10.40 |
| RSI (14) | 29.58 |
| ADX | 22.69 |
| +DI | 13.45 |
| -DI | 24.67 |
| Chandelier Exit (Long, 3 ATRs) | 328.80 |
| Chandelier Exit (Short, 3 ATRs) | 341.20 |
| Upper Bollinger Bands | 357.41 |
| Lower Bollinger Band | 308.84 |
| Percent B (%b) | 0.09 |
| BandWidth | 14.58 |
| MACD Line | -8.15 |
| MACD Signal Line | -6.81 |
| MACD Histogram | -1.3427 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 315.81 | ||||
| Resistance 3 (R3) | 315.50 | 314.25 | 315.34 | ||
| Resistance 2 (R2) | 314.25 | 313.53 | 314.41 | 315.19 | |
| Resistance 1 (R1) | 313.63 | 313.09 | 313.94 | 313.94 | 315.03 |
| Pivot Point | 312.38 | 312.38 | 312.53 | 312.53 | 312.38 |
| Support 1 (S1) | 311.75 | 311.66 | 312.06 | 312.06 | 310.97 |
| Support 2 (S2) | 310.50 | 311.22 | 310.66 | 310.81 | |
| Support 3 (S3) | 309.88 | 310.50 | 310.66 | ||
| Support 4 (S4) | 310.19 |
